Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists

NCT01338363 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01338363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01338363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
August 31, 2015
Enrollment
23,470 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute interstitial nephritis and thrombocytopenia, failure to thrive, gastroenteritis, hospitalized cases of angioneurotic oedema, pneumonia, seizures